Manufacturing News of Note—Thermo Fisher closes on GSK plant; Vetter invests $100M; Lupin names ex-Apotex exec head of quality 

stocks
(Pixabay)

> Waltham, Massachusetts-based Thermo Fisher Scientific has completed its €90 million buyout of a GlaxoSmithKline API site in Cork, Ireland. Release 

> German CDMO Vetter says it will invest $100 million to upgrade its production lines at sites in Germany and the U.S. to increase filling capacity. Story

> Lupin, which has been struggling with manufacturing quality, has named as its new global head of quality Johnny Mikell. He comes from Apotex, another drugmaker with a history of FDA manufacturing issues. Release 

Free Webinar

Striving for Zero in Quality & Manufacturing

Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. This webinar will discuss the role that content management plays in pharmaceutical manufacturing to help companies reach the goal of zero in Quality and Manufacturing.

> Lupin has received a Form 483 with three observations for its Tarapur plant. Story 

> South Plainfield, New Jersey-based biotech PTC Therapeutics has struck a deal with Aldevron to manufacture its gene therapy portfolio. Release 

> Boehringer Ingelheim has completed a $76 million expansion at its plant at Athens, Georgia, which doubles its pet vaccine capacity. Release

> Merck KGaA’s MilliporeSigma has acquired for an undisclosed amount Wilbraham, Massachusetts-based FloDesign Sonics, which has developed an acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Release

Suggested Articles

Mylan is the most recent drugmaker facing the FDA's ire over a tainted API that led to a global recall of "sartan"-based drugs last year.

Merck MSD's $1.2 billion production restructuring has fallen on a site in France, where more than 200 manufacturing and R&D jobs will be swept away.

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job.